Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Mol Endocrinol. 2002 Jun;16(6):1280–1298. doi: 10.1210/mend.16.6.0841

Table 1.

Summary of Complex 2, Otx1, and Ptx1 Binding Site Requirements

graphic file with name nihms230708f11.jpg

Wild-type and mutant oligonucleotides are depicted as used for probes and competitions in EMSA in Figs. 4 and 8 and data not shown. The homeodomain (HD) and SP1/Egr binding sequences are indicated. At right, the ability of each oligonucleotide to bind and compete with complex 2, Otx1, or Ptx1 binding to the LH 121/87 probe is depicted (+++, maximum; +, minimum; and −, no binding).